R. Hou

Pharmacokinetics of silybin nanoparticles in mice bearing SKOV-3 human ovarian carcinoma xenocraft.

Quanhua Zhang, X. Guan, Shuzhen Zhao, 2015, International journal of clinical and experimental medicine.

Pilot study: safety and effectiveness of simple ultrasound-guided high-intensity focused ultrasound ablating uterine leiomyoma with a diameter greater than 10 cm.

Shijin Wang, R. Hou, Yuanyuan Wang, 2017, The British journal of radiology.

Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer

X. Guan, R. Hou, Xueying Zhang, 2013, Patient preference and adherence.

Inhibition effect of silver nanoparticles on herpes simplex virus 2.

X. Guan, R. Hou, R. Hu, 2014, Genetics and molecular research : GMR.

MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.

Shaoru Li, R. Hou, Shaoping Li, 2018, Experimental and therapeutic medicine.

BJRD16760 1..6

Nana Ma, R. Hou, Shenghua Yang, 2017 .

Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA

Zhifang Zhang, X. Guan, Shuzhen Zhao, 2020, Annals of translational medicine.